MultiCell Technologies Inc (MCET)

[Dip66]

At these low prices if the company was smart they would take the current revenue of $500K+ and immediately do a share buyback. This would clean up the share structure to where it is manageable attracting bigger fish. I have only seen ONE pharma company do this before that trades on the pinks and it turned out very well for the company and shareholders. It sucks giving up that revenue although it is made up for by the more sophisticated investors who will only invest with an attractive share structure. You have to give some to get some. This is getting interesting!